Cargando…
Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M
Aberrant inflammation is a hallmark of inflammatory bowel disease (IBD) and colorectal cancer. IRAK-M is a critical negative regulator of TLR signaling and overzealous inflammation. Here we utilize data from human studies and Irak-m(−/−) mice to elucidate the role of IRAK-M in the modulation of gast...
Autores principales: | Rothschild, Daniel E., Zhang, Yao, Diao, Na, Lee, Christina K., Chen, Keqiang, Caswell, Clayton C., Slade, Daniel J., Helm, Richard F., LeRoith, Tanya, Li, Liwu, Allen, Irving C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233813/ https://www.ncbi.nlm.nih.gov/pubmed/27939424 http://dx.doi.org/10.1016/j.ebiom.2016.11.039 |
Ejemplares similares
-
IRAK-M regulation and function in host defense and immune homeostasis
por: Hubbard, Leah L.N., et al.
Publicado: (2010) -
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
por: Bennett, Joshua, et al.
Publicado: (2022) -
Regulatory T Cells in Arterivirus and Coronavirus Infections: Do They Protect Against Disease or Enhance it?
por: Cecere, Thomas E., et al.
Publicado: (2012) -
An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission
por: Li, Weizhong, et al.
Publicado: (2022) -
An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission
por: Li, Weizhong, et al.
Publicado: (2023)